[Hormone determinations during 17-hydroxyprogesterone-capronate therapy].
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D002845:Chromatography; D003124:Colorimetry; D003404:Creatinine / Q000652:urine; D004967:Estrogens / Q000652:urine*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis; D006062:Gonadotropins / Q000652:urine*; D006801:Humans; D006908:Hydroxyprogesterones / Q000378:metabolism* / Q000627:therapeutic use; D007889:Leiomyoma / Q000378:metabolism; D011276:Pregnanediol / Q000652:urine; D002583:Uterine Cervical Neoplasms / Q000378:metabolism; D014594:Uterine Neoplasms / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000614:Aminocaproates; D004967:Estrogens; D006062:Gonadotropins; D006908:Hydroxyprogesterones; D005640:Follicle Stimulating Hormone; D003404:Creatinine; D011276:Pregnanediol
Hormonbestimmungen während der Behandlung mit 17-Hdroxyprogesteron-Capronat.